ASCO Backs Routine ESR1 Testing for Certain Breast Cancers
American Society of Clinical Oncology (ASCO) clinical practice guidelines now…
Browsing Tag
ESR1
Sermonix Pharmaceuticals Shares Details of First-Ever Known Durable Complete Clinical…
Presentation delivered at the ninth-annual Metastatic Breast Cancer Research Conference in Park City, Utah Case was reported during Phase 2 study investigating efficacy of lasofoxifene,…
Sermonix to Present Updated Data from ELAINE-2 Clinical Trial of Lasofoxifene in…
COLUMBUS, Ohio, May 31, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat…